| Literature DB >> 17936560 |
Koji Itahana1, Hua Mao, Aiwen Jin, Yoko Itahana, Hilary V Clegg, Mikael S Lindström, Krishna P Bhat, Virginia L Godfrey, Gerard I Evan, Yanping Zhang.
Abstract
It is believed that Mdm2 suppresses p53 in two ways: transcriptional inhibition by direct binding, and degradation via its E3 ligase activity. To study these functions physiologically, we generated mice bearing a single-residue substitution (C462A) abolishing the E3 function without affecting p53 binding. Unexpectedly, homozygous mutant mice died before E7.5, and deletion of p53 rescued the lethality. Furthermore, reintroducing a switchable p53 by crossing with p53ER(TAM) mice surprisingly demonstrated that the mutant Mdm2(C462A) was rapidly degraded in a manner indistinguishable from that of the wild-type Mdm2. Hence, our data indicate that (1) the Mdm2-p53 physical interaction, without Mdm2-mediated p53 ubiquitination, cannot control p53 activity sufficiently to allow early mouse embryonic development, and (2) Mdm2's E3 function is not required for Mdm2 degradation.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17936560 DOI: 10.1016/j.ccr.2007.09.007
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743